Trademark: 97626126
Word
RYZUMVI
Status
Pending
Status Code
688
Status Date
Tuesday, January 30, 2024
Serial Number
97626126
Mark Type
4000
Filing Date
Monday, October 10, 2022
Published for Opposition
Tuesday, December 5, 2023

Trademark Owner History
OCUPHIRE PHARMA, INC. - Owner At Publication

Classifications
5 PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES AND CONDITIONS
42 Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Trademark Events
Jan 30, 2024
Noa E-Mailed - Sou Required From Applicant
Dec 5, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Published For Opposition
Nov 15, 2023
Notification Of Notice Of Publication E-Mailed
Oct 27, 2023
Approved For Pub - Principal Register
Oct 26, 2023
Teas/Email Correspondence Entered
Oct 25, 2023
Correspondence Received In Law Office
Oct 25, 2023
Teas Response To Office Action Received
Jul 28, 2023
Notification Of Non-Final Action E-Mailed
Jul 28, 2023
Non-Final Action E-Mailed
Jul 28, 2023
Non-Final Action Written
Jul 24, 2023
Assigned To Examiner
Oct 25, 2022
New Application Office Supplied Data Entered
Oct 13, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24